A new trading day began on Monday, with Veracyte Inc (NASDAQ: VCYT) stock price up 3.58% from the previous day of trading, before settling in for the closing price of $41.91. VCYT’s price has ranged from $18.61 to $46.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 35.32%. Meanwhile, its annual earnings per share averaged 135.29%. With a float of $76.57 million, this company’s outstanding shares have now reached $77.49 million.
Considering the fact that the conglomerate employs 815 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 65.47%, operating margin of 2.6%, and the pretax margin is -1.92%.
Veracyte Inc (VCYT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Veracyte Inc is 1.19%, while institutional ownership is 106.26%. The most recent insider transaction that took place on Jan 02 ’25, was worth 403,006. In this transaction Director of this company sold 10,000 shares at a rate of $40.30, taking the stock ownership to the 18,497 shares. Before that another transaction happened on Jan 02 ’25, when Company’s Director proposed sale 10,000 for $39.60, making the entire transaction worth $396,000.
Veracyte Inc (VCYT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 135.29% per share during the next fiscal year.
Veracyte Inc (NASDAQ: VCYT) Trading Performance Indicators
Here are Veracyte Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.20. Likewise, its price to free cash flow for the trailing twelve months is 61.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.14, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 0.64 in one year’s time.
Technical Analysis of Veracyte Inc (VCYT)
Compared to the last year’s volume of 0.68 million, its volume of 0.59 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 81.11%. Additionally, its Average True Range was 1.69.
During the past 100 days, Veracyte Inc’s (VCYT) raw stochastic average was set at 85.25%, which indicates a significant increase from 82.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.09% in the past 14 days, which was higher than the 42.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.62, while its 200-day Moving Average is $29.01. Nevertheless, the first resistance level for the watch stands at $44.60 in the near term. At $45.80, the stock is likely to face the second major resistance level. The third major resistance level sits at $47.09. If the price goes on to break the first support level at $42.11, it is likely to go to the next support level at $40.82. Should the price break the second support level, the third support level stands at $39.62.
Veracyte Inc (NASDAQ: VCYT) Key Stats
With a market capitalization of 3.49 billion, the company has a total of 77,500K Shares Outstanding. Currently, annual sales are 361,050 K while annual income is -74,400 K. The company’s previous quarter sales were 115,860 K while its latest quarter income was 15,160 K.
